Provectus Biopharmaceuticals, Inc. (PVCT)
OTCMKTS
· Delayed Price · Currency is USD
0.0510
-0.0005 (-0.97%)
At close: Apr 28, 2026
PVCT Market Cap
PVCT has a market cap or net worth of $21.43 million as of April 28, 2026. Its market cap has decreased by -46.93% in one year.
Market Cap
21.43M
Enterprise Value
24.17M
Revenue
336.11K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.05
Market Cap Chart
Since April 24, 2002, PVCT's market cap has increased from 4.32K to 21.43M, an increase of 495,834.15%. That is a compound annual growth rate of 42.50%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arch Biopartners | 22.42M |
| Anebulo Pharmaceuticals | 19.71M |
| Harvard Apparatus Regenerative Technology | 27.07M |
| EOM Pharmaceuticals Holdings | 17.08M |
| Oncotelic Therapeutics | 16.79M |
| Zeo ScientifiX | 15.55M |
| Inhibitor Therapeutics | 15.53M |
| HOOKIPA Pharma | 14.15M |